Intrust Bank’s Actinium Pharmaceuticals ATNM Stock Holding History

Intrust Bank’s Portfolio ATNM Stock Details ATNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,333	Closed	-$14K	–	341
2020 Q2	$14K	Hold	1,333	–	–	﹤0.01%	326
2020 Q1	$8K	Hold	1,333	–	–	﹤0.01%	310
2019 Q4	$9K	Hold	1,333	–	–	﹤0.01%	341
2019 Q3	$9K	Hold	1,333	–	–	﹤0.01%	338
2019 Q2	$10K	Hold	1,333	–	–	﹤0.01%	357
2019 Q1	$19K	Hold	1,333	–	–	﹤0.01%	374
2018 Q4	$15K	Hold	1,333	–	–	﹤0.01%	361
2018 Q3	$30K	Buy	1,333 +666	+100%	+$13.6K	0.01%	365
2018 Q2	$13K	Buy	+667	New	+$8.45K	﹤0.01%	366

Other funds holding ATNM

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Intrust Bank's ATNM Position: Q3 2020 in Review

Intrust Bank sold out of Actinium Pharmaceuticals (ATNM) in Q3 2020, closing a stake of 1,333 shares — an estimated $14K sold.

Intrust Bank first reported a position in ATNM in Q2 2018 and held it in 9 quarters. The position peaked at $30K in Q3 2018. 41 funds tracked by Wall St. Rank hold ATNM as of Q3 2020.

Intrust Bank reported no remaining Actinium Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Intrust Bank sold 1,333 Actinium Pharmaceuticals shares in Q3 2020, an estimated $14K.
Intrust Bank first reported a position in Actinium Pharmaceuticals in Q2 2018 and held it in 9 quarters.
Intrust Bank's Actinium Pharmaceuticals position peaked at $30K in Q3 2018.
41 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2020.

Based on Intrust Bank's 13F filing for Q3 2020, filed 5 Nov 2020.